Showing results (551-560 of 812) with videos related to
Sort By:
Pageof 82
The Kurume Medical Journal|February 5, 2000
A so-called carcinosarcoma of the gallbladder in a patient with multiple anomalies--a case reportN Eriguchi, S Aoyagi, M Hara, et al.Pancreas|April 1, 1995
Effect of a new bombesin receptor antagonist, (E)-alkene bombesin isostere, on amylase release from rat pancreatic aciniM Wada, R Doi, R Hosotani, et al.Cancer|June 15, 1995
Lewis Y antigen expression in hepatocellular carcinoma. An immunohistochemical studyM Wakabayashi, T Shiro, T Seki, et al.Journal of Gastroenterology|February 1, 1997
Clinical trial of prophylactic endoscopic variceal ligation for esophageal varicesH Kishimoto, M Sakai, T Kajiyama, et al.Radiation Medicine|March 1, 1989
Postoperative radiation therapy for esophageal cancerY Nishimura, K Ono, M Imamura, et al.Clinical Genetics|March 12, 2014
A comprehensive search for mutations in the PKD1 and PKD2 in Japanese subjects with autosomal dominant polycystic kidney diseaseM Kurashige, K Hanaoka, M Imamura, et al.AJR. American Journal of Roentgenology|October 8, 1998
Percutaneous hepatic infarction therapy for hepatocellular carcinomaM Imamura, Y Shiratori, S Sato, et al.European Journal of Gastroenterology & Hepatology|January 1, 1999
Hepatic infarction following percutaneous ethanol injection therapy for hepatocellular carcinomaT Seki, M Wakabayashi, T Nakagawa, et al.Cancer|December 15, 1993
Loxiglumide (CR1505), a cholecystokinin antagonist, specifically inhibits the growth of human pancreatic cancer lines xenografted into nude miceY Nio, M Tsubono, H Morimoto, et al.Annals of Surgery|January 1, 1995
Anticancer chemosensitivity changes between the original and recurrent tumors after successful chemotherapy selected according to the sensitivity assayY Nio, K Tamura, M Tsubono, et al.Pageof 82